Rallybio Stock Quote RLYB - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.91

Bid

1.91

Ask

1.94

Volume

226,687

1.77 Day's Range 1.92

1.225 52 Week Range 9.14

Market Cap

72.221M

Previous Close

1.84

Open

1.78

Last Trade

150

1.91

(formt)

Last Trade Time

16:06:19

Financial Volume

$ 417,728

VWAP

1.8428

Average Volume (3m)

1,665,422

Shares Outstanding

37,811,970

Dividend Yield

PE Ratio

-0.97

Earnings Per Share (EPS)

-1.97

Revenue

Net Profit

-74.56M

Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening ... Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.rallybio.com.

Headquarters

Wilmington, Delaware, USA

Founded

1970

Rallybio Holdings LLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RLYB. The last closing price for Rallybio was $1.84. Over the last year, Rallybio shares have traded in a share price range of $ 1.225 to $ 9.14.

Rallybio currently has 37,811,970 shares outstanding. The market capitalization of Rallybio is $72.22 million. Rallybio has a price to earnings ratio (PE ratio) of -0.97.

Form S-3 - Registration statement under Securities Act of 1933

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Rallybio Reports First Quarter 2024 Financial Results and Provides Business Updates

- On Track to Initiate RLYB212 Phase 2 Dose Confirmation Trial in Pregnant Women at Higher Risk of FNAIT in 2H 2024 - - $94.2 Million in Cash, Cash Equivalents, and Marketable Securities as of...

Rallybio to Present at the 2024 Citizens JMP Life Sciences Conference

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and...

FNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting

- Data Support HPA-1a Negative Frequency of More than 2% in Nearly 200,000 Screened Pregnant Women - - Among HPA-1a Negative Pregnant Women, Approximately 33% are at Higher Risk for...

Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

- Rallybio to Receive Funding for FNAIT Awareness Initiative and Equity Investment from Johnson & Johnson - Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company...

Rallybio Announces FNAIT Systematic Literature Review to be Presented at the AMCP 2024 Annual Meeting

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.03	-1.54639175258	1.94	2	1.77	154718	1.84334855	CS
4	0.15	8.52272727273	1.76	2	1.54	253748	1.78849488	CS
12	0.1	5.52486187845	1.81	3.46	1.455	1665422	2.77577153	CS
26	-0.54	-22.0408163265	2.45	3.46	1.225	908754	2.66941755	CS
52	-3.29	-63.2692307692	5.2	9.14	1.225	487433	2.93833086	CS
156	-13.01	-87.1983914209	14.92	25.78	1.225	232714	4.78125172	CS
260	-13.01	-87.1983914209	14.92	25.78	1.225	232714	4.78125172	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
FFIEFaraday Future Intelligent Electric Inc	$ 0.80 (14.30%)	4.66M
FLJFLJ Group Limited	$ 0.49 (8.17%)	6.5k
SNCRSynchronoss Technologies Inc	$ 10.81 (8.10%)	2.5k
SNGXSoligenix Inc	$ 0.3868 (6.41%)	258
TIRXTian Ruixiang Holdings Ltd	$ 3.6898 (6.03%)	475
LSDILucy Scientific Discovery Inc	$ 0.4311 (-15.47%)	3.33k
BKYIBIO key International Inc	$ 1.40 (-14.10%)	2.01k
RETOReTo Eco Solutions Inc	$ 1.56 (-12.36%)	7.19k
SLNASelina Hospitality PLC	$ 0.1108 (-9.03%)	2.18M
GLUEMonte Rosa Therapeutics Inc	$ 4.80 (-8.57%)	3.91k
FFIEFaraday Future Intelligent Electric Inc	$ 0.80 (14.30%)	4.66M
SINTSiNtx Technologies Inc	$ 0.1334 (4.87%)	3.51M
PEGYPineapple Energy Inc	$ 0.0823 (-3.18%)	2.2M
SLNASelina Hospitality PLC	$ 0.1108 (-9.03%)	2.18M
SIRISirius XM Holdings Inc	$ 3.04 (-0.16%)	1.38M